Stay updated on JNJ-67856633 in NHL & CLL Clinical Trial
Sign up to get notified when there's something new on the JNJ-67856633 in NHL & CLL Clinical Trial page.

Latest updates to the JNJ-67856633 in NHL & CLL Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new Locations section has been added and the state location headings (California, Nebraska, New York, Texas) have been reorganized under it; the old location sections and the HHS Vulnerability Disclosure link were removed, and the page revision updated to v3.3.3.SummaryDifference0.4%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedRevision: v3.3.2 replaces v3.3.1 on the page. The study details and layout appear unchanged.SummaryDifference0.0%

- Check42 days agoChange DetectedSite revision updated from v3.2.0 to v3.3.1. The Study Details content and study-related information appear unchanged in the screenshots.SummaryDifference0.0%

- Check49 days agoChange DetectedRemoved the general government funding status notice from the page; all study-specific information remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check63 days agoChange DetectedNo significant changes to the Study Details page content were detected; observed differences seem to be minor UI updates.SummaryDifference0.4%

- Check92 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference3%

Stay in the know with updates to JNJ-67856633 in NHL & CLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JNJ-67856633 in NHL & CLL Clinical Trial page.